Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
Published in Circulation • Nov 1, 1993
Authors:,,
A A van den Bos
J W Deckers
G R Heyndrickx
Abstract
BACKGROUND: Enhanced thrombin activity has been associated with acute and long-term complications following balloon angioplasty (percutaneous transluminal coronary angioplasty (PTCA). We evaluated, in a 2-to-1 randomized, double-blind trial, the effects of recombinant hirudin, CGP 39 393, relative t...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!